Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Proposed OTC Acetaminophen Warnings Not Supported By Science – McNeil

This article was originally published in The Tan Sheet

Executive Summary

Existing science on the safety and efficacy of OTC acetaminophen does not substantiate several FDA-proposed warnings to be included in labeling for the analgesic, McNeil Consumer Healthcare asserts
Advertisement

Related Content

FDA Expands Acetaminophen, NSAID Labeling Beyond Tentative Final Rule
FDA Expands Acetaminophen, NSAID Labeling Beyond Tentative Final Rule
FDA Expands Acetaminophen, NSAID Labeling Beyond Tentative Final Rule
Final rule for pain reliever labels
Final rule for pain reliever labels
Final rule for pain reliever labels
Top Stories Of 2007: From Talk Of BTC To Supplement GMPs
McNeil Sponsors “Answers In The Aisles” Web Site For OTC Analgesic Safety
FDA Proposes Liver, GI Risk Warnings For OTC Pain Relievers
FDA Proposes Liver, GI Risk Warnings For OTC Pain Relievers

Topics

Advertisement
UsernamePublicRestriction

Register

PS100601

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel